Parkman Healthcare Partners as of March 31, 2026
Portfolio Holdings for Parkman Healthcare Partners
Parkman Healthcare Partners holds 90 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Stryker Corporation (SYK) | 5.2 | $51M | 155k | 328.59 | |
| Dex (DXCM) | 4.5 | $43M | 690k | 62.80 | |
| Kalvista Pharmaceuticals | 3.8 | $37M | 1.8M | 20.13 | |
| Insulet Corporation (PODD) | 3.4 | $33M | 157k | 209.84 | |
| Eli Lilly & Co. (LLY) | 3.3 | $32M | 35k | 919.77 | |
| Ptc Therapeutics I (PTCT) | 3.0 | $29M | 431k | 68.13 | |
| Xenon Pharmaceuticals (XENE) | 3.0 | $29M | 497k | 58.15 | |
| Boston Scientific Corporation (BSX) | 2.9 | $28M | 449k | 62.75 | |
| CVS Caremark Corporation (CVS) | 2.9 | $28M | 387k | 71.82 | |
| Arcus Biosciences Incorporated (RCUS) | 2.7 | $26M | 1.2M | 21.60 | |
| Livanova SHS (LIVN) | 2.6 | $26M | 404k | 63.56 | |
| Zimmer Holdings (ZBH) | 2.5 | $24M | 270k | 90.42 | |
| Mbx Biosciences (MBX) | 2.5 | $24M | 800k | 29.85 | |
| Biosante Pharmaceuticals (ANIP) | 2.2 | $22M | 281k | 76.90 | |
| Syndax Pharmaceuticals (SNDX) | 2.2 | $21M | 902k | 23.36 | |
| Qiagen Nv Ord Shares (QGEN) | 2.1 | $20M | 500k | 40.04 | |
| Envista Hldgs Corp (NVST) | 1.9 | $18M | 712k | 25.37 | |
| Eyepoint Com New (EYPT) | 1.8 | $18M | 1.4M | 12.89 | |
| Abbvie (ABBV) | 1.7 | $16M | 75k | 217.49 | |
| BioCryst Pharmaceuticals (BCRX) | 1.7 | $16M | 1.7M | 9.52 | |
| Iqvia Holdings (IQV) | 1.5 | $15M | 87k | 170.54 | |
| Agios Pharmaceuticals (AGIO) | 1.4 | $14M | 404k | 33.83 | |
| Illumina (ILMN) | 1.4 | $14M | 110k | 123.26 | |
| Edwards Lifesciences (EW) | 1.4 | $13M | 167k | 80.08 | |
| Neurocrine Biosciences (NBIX) | 1.3 | $13M | 99k | 131.74 | |
| Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA) | 1.3 | $13M | 259k | 48.15 | |
| Assembly Biosciences Com New (ASMB) | 1.2 | $11M | 411k | 27.75 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 1.2 | $11M | 232k | 48.20 | |
| McKesson Corporation (MCK) | 1.1 | $11M | 13k | 865.36 | |
| Stoke Therapeutics (STOK) | 1.1 | $11M | 337k | 32.56 | |
| Miragen Therapeutics (VRDN) | 1.1 | $11M | 558k | 19.56 | |
| Waystar Holding Corp (WAY) | 1.1 | $11M | 443k | 24.11 | |
| Mineralys Therapeutics (MLYS) | 1.1 | $10M | 380k | 27.09 | |
| Edgewise Therapeutics (EWTX) | 1.0 | $10M | 323k | 31.50 | |
| Xeris Pharmaceuticals (XERS) | 1.0 | $10M | 1.7M | 5.80 | |
| Tenet Healthcare Corp Com New (THC) | 1.0 | $9.5M | 50k | 188.71 | |
| CryoLife (AORT) | 1.0 | $9.2M | 252k | 36.62 | |
| Nuvalent Inc-a (NUVL) | 0.9 | $9.0M | 88k | 102.45 | |
| Alphatec Hldgs Com New (ATEC) | 0.9 | $9.0M | 824k | 10.88 | |
| Alnylam Pharmaceuticals (ALNY) | 0.9 | $8.9M | 27k | 330.87 | |
| Axogen (AXGN) | 0.9 | $8.9M | 268k | 33.13 | |
| Immunome (IMNM) | 0.9 | $8.8M | 404k | 21.87 | |
| Amylyx Pharmaceuticals (AMLX) | 0.9 | $8.6M | 622k | 13.90 | |
| IDEXX Laboratories (IDXX) | 0.9 | $8.4M | 15k | 561.89 | |
| Waters Corporation (WAT) | 0.8 | $7.9M | 26k | 297.80 | |
| Adaptive Biotechnologies Cor (ADPT) | 0.8 | $7.7M | 552k | 13.88 | |
| Upstream Bio (UPB) | 0.7 | $7.1M | 787k | 9.00 | |
| Erasca (ERAS) | 0.7 | $6.6M | 407k | 16.18 | |
| Apogee Therapeutics (APGE) | 0.7 | $6.5M | 78k | 84.17 | |
| Cooper Cos (COO) | 0.7 | $6.4M | 90k | 71.50 | |
| Absci Corp (ABSI) | 0.6 | $5.6M | 1.9M | 3.00 | |
| Tango Therapeutics (TNGX) | 0.6 | $5.6M | 266k | 20.92 | |
| Moderna Put Put Option | 0.5 | $5.1M | 100k | 50.80 | |
| Caredx (CDNA) | 0.5 | $5.1M | 291k | 17.36 | |
| Urogen Pharma (URGN) | 0.5 | $4.9M | 275k | 17.98 | |
| Ultragenyx Pharmaceutical (RARE) | 0.5 | $4.9M | 235k | 20.95 | |
| 4d Molecular Therapeutics In (FDMT) | 0.5 | $4.9M | 523k | 9.31 | |
| Irhythm Technologies (IRTC) | 0.5 | $4.7M | 40k | 118.02 | |
| Minimed Group (MMED) | 0.5 | $4.7M | 317k | 14.92 | |
| Si-bone (SIBN) | 0.5 | $4.7M | 374k | 12.63 | |
| Carlsmed (CARL) | 0.5 | $4.7M | 521k | 9.05 | |
| Optimizerx Corp Com New (OPRX) | 0.5 | $4.6M | 729k | 6.28 | |
| Vir Biotechnology (VIR) | 0.5 | $4.5M | 500k | 8.96 | |
| Supernus Pharmaceuticals (SUPN) | 0.5 | $4.4M | 85k | 51.69 | |
| Caris Life Sciences (CAI) | 0.4 | $4.1M | 230k | 17.88 | |
| CVRX (CVRX) | 0.4 | $4.1M | 430k | 9.46 | |
| Inspiremd (NSPR) | 0.4 | $3.9M | 2.4M | 1.63 | |
| Cogent Biosciences (COGT) | 0.4 | $3.9M | 100k | 38.49 | |
| Amneal Pharmaceuticals Com Stk Cl A (AMRX) | 0.4 | $3.7M | 301k | 12.43 | |
| Annexon (ANNX) | 0.4 | $3.7M | 674k | 5.54 | |
| Align Technology (ALGN) | 0.4 | $3.6M | 21k | 171.43 | |
| Uniqure Nv SHS (QURE) | 0.3 | $3.4M | 207k | 16.35 | |
| Genedx Holdings Corp Com Cl A (WGS) | 0.3 | $3.3M | 51k | 64.22 | |
| Veracyte (VCYT) | 0.3 | $3.3M | 101k | 32.21 | |
| Castle Biosciences (CSTL) | 0.3 | $3.1M | 126k | 24.55 | |
| Compass Pathways Sponsored Ads (CMPS) | 0.3 | $3.1M | 554k | 5.53 | |
| Bright Minds Biosciences Com New (DRUG) | 0.3 | $2.9M | 40k | 72.97 | |
| Solid Biosciences Com New (SLDB) | 0.2 | $2.2M | 309k | 7.20 | |
| Butterfly Network Com Cl A (BFLY) | 0.2 | $2.2M | 545k | 4.04 | |
| Quidel Corp (QDEL) | 0.2 | $1.7M | 102k | 16.43 | |
| Rxsight (RXST) | 0.2 | $1.5M | 250k | 6.16 | |
| Quanterix Ord (QTRX) | 0.1 | $1.2M | 342k | 3.52 | |
| Pulse Biosciences (PLSE) | 0.1 | $1.1M | 50k | 21.59 | |
| Pulmonx Corp (LUNG) | 0.1 | $975k | 756k | 1.29 | |
| Maze Therapeatics (MAZE) | 0.1 | $951k | 32k | 29.85 | |
| Adma Biologics (ADMA) | 0.1 | $743k | 82k | 9.01 | |
| Edap Tms S A Sponsored Adr (FOCL) | 0.1 | $576k | 155k | 3.72 | |
| Ovid Therapeutics (OVID) | 0.0 | $462k | 208k | 2.22 | |
| Accuray Incorporated (ARAY) | 0.0 | $343k | 885k | 0.39 | |
| Entera Bio SHS (ENTX) | 0.0 | $320k | 289k | 1.11 |
